封面
市場調查報告書
商品編碼
1535238

ERCP及PTC設備市場:各市場區隔規模,佔有率,法律規章,償付,手術,2033年為止的預測

ERCP and PTC Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日期: | 出版商: GlobalData | 英文 | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

內視鏡逆行性胰膽管攝影 (ERCP) 是一種針對肝臟和胰臟引流管(包括膽管、膽囊和胰管)的內視鏡和放射學聯合手術。當膽管嚴重狹窄且難以透過內視鏡觀察時,或當先前的手術使內視鏡進入變得困難時,經皮肝穿刺膽管造影(PTC)對於進入膽管非常有用。

ERCP 和 PTC 通常用於治療阻塞性黃疸和控制膽漏(無論是良性還是惡性)。它也用於預防胰臟炎以及排出膽囊和胰液。這些裝置主要透過兩種方式放置:內視鏡逆行性胰膽管攝影(ERCP)和經皮肝穿刺膽管攝影(PTC)。

本報告提供全球ERCP及PTC設備市場相關資料詳細考察,提供市場上競爭情形,SWOT分析,到2033年為止的市場預測,地區,各國的趨勢等資訊。

目錄

已上市的ERCP及PTC設備和不斷變化的競爭格局

  • 主要的產業趨勢洞察
  • ERCP及PTC設備的各市場區隔整體市場收益和2015年~2033年的市場展望
  • 各市場區隔的手術總數,台數,平均銷售價格,市場價值相關詳細資料

世界,地區,各國洞察

  • ERCP及PTC設備市場SWOT分析
  • ERCP及PTC設備市場相關競爭動態的洞察和趨勢
  • 各國醫療制度概要
  • 各國償付政策
  • 各國醫療技術相關法規狀況
簡介目錄
Product Code: GDME715MM

ERCP and PTC Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a combined endoscopic and radiologic procedure for the ducts draining the liver and pancreas which includes bile ducts, gallbladder, and pancreatic ducts. Percutaneous Transhepatic Cholangiography (PTC) is useful in accessing the biliary tree when a high-grade stricture precludes endoscopic visualization or when prior surgery makes endoscopic access difficult.

ERCP and PTC devices are often used in the treatment of obstructive jaundice from either benign or malignant causes and in the management of biliary leaks. These devices are also used for preventing pancreatitis and to drain the gallbladder and pancreatic fluids. These devices are placed through two major procedures: Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and Percutaneous transhepatic cholangiography (PTC).

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed ERCP and PTC Devices and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total ERCP and PTC Devices market revenue by segment and market outlooks from 2015-2033.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for ERCP and PTC Devices market.
  • Competitive dynamics insights and trends provided for ERCP and PTC Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, ConMed Corp, Cook Medical Inc, Olympus Corp, Merit Medical Systems Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the ERCP and PTC devices market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving ERCP and PTC Devices market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the ERCP and PTC Devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific ERCP and PTC Devices market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.